PURPOSES: We investigated whether circulating endothelial progenitor cells (EPCs) can be used as a cell source for the creation of a tissue-engineered heart valve (TEHV). METHODS: Trileaflet valved conduits were fabricated using nonwoven polyglycolic acid/poly-4-hydroxybutyrate polymer. Ovine peripheral blood EPCs were dynamically seeded onto a valved conduit and incubated for 7, 14, and 21 days. RESULTS: Before seeding, EPCs were shown to express CD31(+), eNOS(+), and VE-Cadherin(+) but not alpha-smooth muscle actin. Histological analysis demonstrated relatively homogenous cellular ingrowth throughout the valved conduit. TEHV constructs revealed the presence of endothelial cell (EC) markers and alpha-smooth muscle actin(+) cells comparable with native valves. Protein levels were comparable with native valves and exceeded those in unseeded controls. EPC-TEHV demonstrated a temporal pattern of matrix metalloproteinases-2/9 expression and tissue inhibitors of metalloproteinase activities comparable to that of native valves. Mechanical properties of EPC-TEHV demonstrated significantly greater stiffness than that of the unseeded scaffolds and native valves. CONCLUSIONS: Circulating EPC appears to have the potential to provide both interstitial and endothelial functions and could potentially serve as a single-cell source for construction of autologous heart valves.
PURPOSES: We investigated whether circulating endothelial progenitor cells (EPCs) can be used as a cell source for the creation of a tissue-engineered heart valve (TEHV). METHODS: Trileaflet valved conduits were fabricated using nonwoven polyglycolic acid/poly-4-hydroxybutyrate polymer. Ovine peripheral blood EPCs were dynamically seeded onto a valved conduit and incubated for 7, 14, and 21 days. RESULTS: Before seeding, EPCs were shown to express CD31(+), eNOS(+), and VE-Cadherin(+) but not alpha-smooth muscle actin. Histological analysis demonstrated relatively homogenous cellular ingrowth throughout the valved conduit. TEHV constructs revealed the presence of endothelial cell (EC) markers and alpha-smooth muscle actin(+) cells comparable with native valves. Protein levels were comparable with native valves and exceeded those in unseeded controls. EPC-TEHV demonstrated a temporal pattern of matrix metalloproteinases-2/9 expression and tissue inhibitors of metalloproteinase activities comparable to that of native valves. Mechanical properties of EPC-TEHV demonstrated significantly greater stiffness than that of the unseeded scaffolds and native valves. CONCLUSIONS: Circulating EPC appears to have the potential to provide both interstitial and endothelial functions and could potentially serve as a single-cell source for construction of autologous heart valves.
Authors: Virna L Sales; George C Engelmayr; Bret A Mettler; John A Johnson; Michael S Sacks; John E Mayer Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Cecilia A Fernández; Li Yan; Gwendolyn Louis; Jiang Yang; Jeffery L Kutok; Marsha A Moses Journal: Clin Cancer Res Date: 2005-08-01 Impact factor: 12.531
Authors: Elena Aikawa; Peter Whittaker; Mark Farber; Karen Mendelson; Robert F Padera; Masanori Aikawa; Frederick J Schoen Journal: Circulation Date: 2006-03-14 Impact factor: 29.690
Authors: George C Engelmayr; Elena Rabkin; Fraser W H Sutherland; Frederick J Schoen; John E Mayer; Michael S Sacks Journal: Biomaterials Date: 2005-01 Impact factor: 12.479
Authors: George C Engelmayr; Daniel K Hildebrand; Fraser W H Sutherland; John E Mayer; Michael S Sacks Journal: Biomaterials Date: 2003-06 Impact factor: 12.479
Authors: M K Sewell-Loftin; Young Wook Chun; Ali Khademhosseini; W David Merryman Journal: J Cardiovasc Transl Res Date: 2011-07-13 Impact factor: 4.132
Authors: Donal MacGrogan; Guillermo Luxán; Anita Driessen-Mol; Carlijn Bouten; Frank Baaijens; José Luis de la Pompa Journal: Cold Spring Harb Perspect Med Date: 2014-11-03 Impact factor: 6.915
Authors: Petra E Dijkman; Emanuela S Fioretta; Laura Frese; Francesco S Pasqualini; Simon P Hoerstrup Journal: Transfus Med Hemother Date: 2016-07-26 Impact factor: 3.747
Authors: Yung-Nung Chiu; Russell A Norris; Gretchen Mahler; Andrew Recknagel; Jonathan T Butcher Journal: Tissue Eng Part A Date: 2010-07-14 Impact factor: 3.845
Authors: Praveen K Sobhan; Mahendra Seervi; Jeena Joseph; Saneesh Varghese; Prakash Rajappan Pillai; Divya Mundackal Sivaraman; Jackson James; Roshin Elizabeth George; K E Elizabeth; T R Santhoshkumar; M Radhakrishna Pillai Journal: Tissue Eng Part C Methods Date: 2012-10-01 Impact factor: 3.056
Authors: Robert B Hinton; Jennifer Adelman-Brown; Sandra Witt; Varun K Krishnamurthy; Hanna Osinska; Bhuvaneswari Sakthivel; Jeanne F James; Dean Y Li; Daria A Narmoneva; Robert P Mecham; D Woodrow Benson Journal: Circ Res Date: 2010-06-24 Impact factor: 17.367
Authors: L A Hockaday; K H Kang; N W Colangelo; P Y C Cheung; B Duan; E Malone; J Wu; L N Girardi; L J Bonassar; H Lipson; C C Chu; J T Butcher Journal: Biofabrication Date: 2012-08-23 Impact factor: 9.954